SUMMARYWe have identified regions of the major capsid protein, L1, of the human papillomavirus (HPV) type 16 , that are recognized by five monoclonal antibodies (MAbs) raised to a bacterial fusion protein containing residues 172 to 375 of HPV-16 L1. All five MAbs recognized HPV-16-infected tissue sections by immunohistochemistry, but not sections infected with HPV-la (cutaneous warts), HPV-6b or -11 (genital warts). MAbs 3D1, 5A4 and 1D6 also recognized HPV-2-infected sections (cutaneous warts); MAb 8C4 recognized only sections containing HPV-16. Four MAbs (8C4, 3D1, 1D6 and 5A4) recognized a synthetic peptide corresponding to residues 269 to 284 of HPV-16 L1; within this region a minimum antibody binding site was identified, a tripeptide 276 to 278. However the complete epitope appears to extend beyond these residues and beyond HPV-16 L1 (269 to 284). The fifth MAb, 1C6, recognized bacterial fusion proteins containing HPV-6b L1, -16 L1 or -18 L1 using immunoblots, yet appeared HPV-16-specific when tested on infected tissue sections. This MAb recognized five amino acids within a different region of HPV-16 L1 (residues 299 to 313).
INTRODUCTIONPapillomaviruses infect avian, reptile and mammalian hosts, causing epithelial proliferation (Sundberg, 1987). Humans are susceptible to at least 58 types of papillomaviruses. Human papillomavirus (HPV) types 16, 18, 31, 33 and 52 which cause genital infections have been associated with high grade cervical intraepitheliat neoptasia lesions and invasive carcinoma, and other genital HPV types (e.g. HPV-6b and HPV-11) are more commonly associated with benign conditions such as genital warts (McCance, 1986). If the relationship between certain types of HPV and pre-invasive and invasive cancer of the cervix is proven to be of a causal rather than casual nature, rapid and accurate diagnosis of the type of HPV infection is likely to be important in the clinical management of patients with these diseases. At present, diagnosis of the exact type of HPV infection relies upon nucleic acid hybridization techniques, which are time-consuming and expensive when compared to immunohistochemical or serological methods of viral identification. A serological test for exposure to high risk HPV types would thus provide an easier method of identifying patients who may be at greatest risk of developing a malignant disease.The major capsid protein (L 1) of papillomaviruses, which is the most abundant virus-encoded protein, is highly conserved between different types, with amino acid homologies as high as 80~ existing between some L1 proteins from different papillomavirus types. As a consequence